Company Frontier Biotechnologies Inc.

688221

CNE100005XF5

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
6.36 ^CNY	-0.47%		-3.64%	-35.89%

25/04	Frontier Biotechnologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23/02	Frontier Biotechnologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Frontier Biotechnologies Inc is a China-based company engaged in research and development, production and sales of innovative drugs. The Company's products include Aikening and Combination regiment of Albuvirtide (ABT) + 3BNC117 which is during clinical stage for treatment of human immunodeficiency virus (HIV). Its clinical-stage products also include transdermal analgesic patch AB001 for treating muscle, skeleton and joint pain. The Company conducts its businesses within the China market and to overseas markets.

Number of employees: 395

CNY in Million	2022	Weight	2023	Weight	Delta
Innovative Drugs 100.0 %	85	100.0 %	114	100.0 %	+34.82%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	85	100.0 %	114	100.0 %	+34.82%

Managers	Title	Age	Since
Rong Jian Lu FOU	Founder	62	15/13/15
Dong Xie FOU	Founder	58	15/13/15
Chang Jin Wang FOU	Founder	66	15/13/15
Qi Shao DFI	Director of Finance/CFO	44	01/15/01
Xiao Hong Zheng COO	Chief Operating Officer	62	01/19/01
Yu Ting Zhu ADM	Chief Administrative Officer	35	01/14/01
Li Na Bao IRC	Investor Relations Contact	-	01/16/01
Qian Ya Gao SEC	Corporate Secretary	38	01/19/01

Members of the board	Title	Age	Since
Chang Jin Wang FOU	Founder	66	15/13/15
Guang Ji Wang BRD	Director/Board Member	71	24/22/24
Yuan Tao Cao BRD	Director/Board Member	43	26/18/26
Dong Xie FOU	Founder	58	15/13/15
Chi Kit Ng BRD	Director/Board Member	51	10/19/10
Qian Ya Gao SEC	Corporate Secretary	38	01/19/01
Rong Jian Lu FOU	Founder	62	15/13/15
Kai Chen BRD	Director/Board Member	65	10/19/10
Zhi Zhong Jiang CHM	Chairman	42	01/14/01
Yu Ting Zhu ADM	Chief Administrative Officer	35	01/14/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	374,578,653	194,665,953 ( 51.97 %)	0	51.97 %

Name	Equities	%	Valuation
Xiao Chen Zhang 5.169 %	10,633,104	5.169 %	10 M ¥
Beijing Ruifeng Investment Management Co. Ltd. 4.327 %	8,902,400	4.327 %	8 M ¥
UBS Asset Management Switzerland AG 2.250 %	4,629,271	2.250 %	4 M ¥
Quan Zhou 1.894 %	3,895,662	1.894 %	4 M ¥
Shenzhen Capital Group Co., Ltd. 1.543 %	3,173,400	1.543 %	3 M ¥
Guodu Venture Capital Co., Ltd. 1.439 %	2,960,769	1.439 %	3 M ¥
Wei Deng 1.351 %	2,778,696	1.351 %	3 M ¥
Gen Cai Yu 1.288 %	2,650,233	1.288 %	2 M ¥
Zhuhai Huajin Innovation Investment Co., Ltd. 1.215 %	2,500,000	1.215 %	2 M ¥
Hui Xie 1.159 %	2,383,423	1.159 %	2 M ¥

Name	Equities	%	Valuation
Dong Xie 67.30 %	113,636,250	67.30 %	103 M ¥
Rong Jian Lu 12.88 %	21,743,750	12.88 %	20 M ¥
Chang Jin Wang 12.47 %	21,059,500	12.47 %	19 M ¥
Deguang Tianjin Investment Partnership LP 3.503 %	5,915,000	3.503 %	5 M ¥
Jiezheng Investment Group Co. Ltd. 3.069 %	5,181,347	3.069 %	5 M ¥

Frontier Biotechnologies, Inc. (China)

11/F, Building E-2, Greenland Window Dongshan Street

211199, Nanjing

http://www.frontierbiotech.com

address Frontier Biotechnologies Inc.(688221)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
FRONTIER BIOTECHNOLOGIES INC.	-35.89%	33Cr
KYOWA KIRIN CO. LTD.	+8.35%	872.08Cr
SK BIOPHARMACEUTICALS CO., LTD.	-16.83%	478.98Cr
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+47.36%	462.18Cr
YUHAN CORPORATION	+1.74%	382.39Cr
INDIVIOR PLC	+14.51%	233.24Cr
BETTA PHARMACEUTICALS CO., LTD.	-26.23%	219.75Cr
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+15.63%	209.63Cr
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-34.87%	203.91Cr
VELOXIS PHARMACEUTICALS A/S	-0.50%	164.41Cr

Specialty & Advanced Pharmaceuticals